These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6095752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA, Polk RE, Kerkering TM, Patterson P, Baggett J.
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D, Koeppe P.
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
    Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N.
    Eur J Clin Pharmacol; 1985; 28(3):327-31. PubMed ID: 2861096
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A, Lettieri J, Blum R, Millikin S, Sica D, Heller AH.
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [Abstract] [Full Text] [Related]

  • 15. Effect of probenecid on the pharmacokinetics of cefmenoxime.
    Sennello LT, Quinn D, Rollins DE, Tolman KG, Sonders RC.
    Antimicrob Agents Chemother; 1983 Jun; 23(6):803-7. PubMed ID: 6311084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.
    Halstenson CE, Guay DR, Opsahl JA, Hirata CA, Olanoff LS, Novak E, Ko H, Cathcart KS, Matzke GR.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):519-23. PubMed ID: 2344159
    [Abstract] [Full Text] [Related]

  • 18. Cefsulodin pharmacokinetics in patients with various degrees of renal function.
    Matzke GR, Keane WF.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):369-73. PubMed ID: 6847169
    [Abstract] [Full Text] [Related]

  • 19. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment.
    Patel IH, Sugihara JG, Weinfeld RE, Wong EG, Siemsen AW, Berman SJ.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment.
    Boike SC, Pue MA, Freed MI, Audet PR, Fairless A, Ilson BE, Zariffa N, Jorkasky DK.
    Clin Pharmacol Ther; 1994 Apr; 55(4):418-26. PubMed ID: 8162668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.